Anticancer Drugs Market 2027 By Drug Type, Therapy Type, Cancer Type and Geography | The Insight Partners

Anticancer Drugs Market to 2027 - Global Analysis and Forecasts by Drug Type (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs); Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy); Cancer Type (Lung Cancer, Breast Cancer, Leukemia, Colorectal Cancer) and Geography

Report Code: TIPRE00004582 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
The oncology drug also known as anti-cancer drugs or anti-neoplastic drugs, anticancer drug are agents that can be used alone or in combination to control or destroy cancerous cells. There are many different types of cancer drugs available in the market. Some treat cancer and others help to relieve symptoms such as sickness and pain. The type of drugs prescribed to the patient depends on type of cancer the patient has. Some cancer drugs can be taken as tablets, suppositories or patches. Cancer drugs such as chemotherapy are usually given in cycles over several months.

MARKET DYNAMICS
Increasing in various cancer conditions, growing advancements in therapies (biological and targeted drug therapies), and rise in geriatric population are the major factors driving the growth of the global anticancer drugs market. The awareness about the cancer drug and their availability further boosts the market growth. Also the rise in number of anticancer drugs in pipeline and increase in demand leads to the very new opportunities for the market players. While the high cost of drug and the reverse action associated with cancer drug impede the growth of market.

MARKET SCOPE
The "Global Anticancer Drugs Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of anticancer drugs market with detailed market segmentation by drug type, therapy type, cancer type and geography. The global anticancer drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading anticancer drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global anticancer drugs Market is segmented on the basis of drug type, therapy type, and cancer type. Based drug type, the market is segmented as cytotoxic drugs, targeted drugs, and hormonal drugs. On the basis of the therapy type the segments is classified as chemotherapy, targeted therapy, and immunotherapy. On the basis of the cancer type the market segmentation is classified as lung cancer, breast cancer, leukemia, and colorectal cancer.

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global anticancer drugs market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anticancer drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anticancer drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anticancer drugs market in these regions.

MARKET PLAYERS
The reports cover key developments in the anticancer drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anticancer drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for anticancer drugs in the global market. Below mentioned is the list of few companies engaged in the anticancer drugs market.

The report also includes the profiles of key anticancer drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Celgene Corporation
  • F. Hoffmann-la Roche ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anticancer Drugs Market - By Drug Type
1.3.2 Anticancer Drugs Market - By Therapy Type
1.3.3 Anticancer Drugs Market - By Cancer Type
1.3.4 Anticancer Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ANTICANCER DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTICANCER DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTICANCER DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTICANCER DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTICANCER DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTICANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. CYTOTOXIC DRUGS
7.3.1. Overview
7.3.2. Cytotoxic Drugs Market Forecast and Analysis
7.3.3. Alkylating Agents Market
7.3.3.1. Overview
7.3.3.2. Alkylating Agents Market Forecast and Analysis
7.3.4. Antimetabolites Market
7.3.4.1. Overview
7.3.4.2. Antimetabolites Market Forecast and Analysis
7.4. TARGETED DRUGS
7.4.1. Overview
7.4.2. Targeted Drugs Market Forecast and Analysis
7.4.3. Monoclonal Antibodies and Tyrosine Kinase Inhibitors Market
7.4.3.1. Overview
7.4.3.2. Monoclonal Antibodies and Tyrosine Kinase Inhibitors Market Forecast and Analysis
7.4.4. Tyrosine Kinase Inhibitors Market
7.4.4.1. Overview
7.4.4.2. Tyrosine Kinase Inhibitors Market Forecast and Analysis
7.5. HORMONAL DRUGS
7.5.1. Overview
7.5.2. Hormonal Drugs Market Forecast and Analysis
8. ANTICANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY TYPE
8.1. OVERVIEW
8.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
8.3. CHEMOTHERAPY
8.3.1. Overview
8.3.2. Chemotherapy Market Forecast and Analysis
8.4. TARGETED THERAPY
8.4.1. Overview
8.4.2. Targeted Therapy Market Forecast and Analysis
8.5. IMMUNOTHERAPY
8.5.1. Overview
8.5.2. Immunotherapy Market Forecast and Analysis
9. ANTICANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - CANCER TYPE
9.1. OVERVIEW
9.2. CANCER TYPE MARKET FORECASTS AND ANALYSIS
9.3. LUNG CANCER
9.3.1. Overview
9.3.2. Lung Cancer Market Forecast and Analysis
9.4. BREAST CANCER
9.4.1. Overview
9.4.2. Breast Cancer Market Forecast and Analysis
9.5. LEUKEMIA
9.5.1. Overview
9.5.2. Leukemia Market Forecast and Analysis
9.6. COLORECTAL CANCER
9.6.1. Overview
9.6.2. Colorectal Cancer Market Forecast and Analysis
10. ANTICANCER DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Anticancer Drugs Market Overview
10.1.2 North America Anticancer Drugs Market Forecasts and Analysis
10.1.3 North America Anticancer Drugs Market Forecasts and Analysis - By Drug Type
10.1.4 North America Anticancer Drugs Market Forecasts and Analysis - By Therapy Type
10.1.5 North America Anticancer Drugs Market Forecasts and Analysis - By Cancer Type
10.1.6 North America Anticancer Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Anticancer Drugs Market
10.1.6.1.1 United States Anticancer Drugs Market by Drug Type
10.1.6.1.2 United States Anticancer Drugs Market by Therapy Type
10.1.6.1.3 United States Anticancer Drugs Market by Cancer Type
10.1.6.2 Canada Anticancer Drugs Market
10.1.6.2.1 Canada Anticancer Drugs Market by Drug Type
10.1.6.2.2 Canada Anticancer Drugs Market by Therapy Type
10.1.6.2.3 Canada Anticancer Drugs Market by Cancer Type
10.1.6.3 Mexico Anticancer Drugs Market
10.1.6.3.1 Mexico Anticancer Drugs Market by Drug Type
10.1.6.3.2 Mexico Anticancer Drugs Market by Therapy Type
10.1.6.3.3 Mexico Anticancer Drugs Market by Cancer Type
10.2. EUROPE
10.2.1 Europe Anticancer Drugs Market Overview
10.2.2 Europe Anticancer Drugs Market Forecasts and Analysis
10.2.3 Europe Anticancer Drugs Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Anticancer Drugs Market Forecasts and Analysis - By Therapy Type
10.2.5 Europe Anticancer Drugs Market Forecasts and Analysis - By Cancer Type
10.2.6 Europe Anticancer Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Anticancer Drugs Market
10.2.6.1.1 Germany Anticancer Drugs Market by Drug Type
10.2.6.1.2 Germany Anticancer Drugs Market by Therapy Type
10.2.6.1.3 Germany Anticancer Drugs Market by Cancer Type
10.2.6.2 France Anticancer Drugs Market
10.2.6.2.1 France Anticancer Drugs Market by Drug Type
10.2.6.2.2 France Anticancer Drugs Market by Therapy Type
10.2.6.2.3 France Anticancer Drugs Market by Cancer Type
10.2.6.3 Italy Anticancer Drugs Market
10.2.6.3.1 Italy Anticancer Drugs Market by Drug Type
10.2.6.3.2 Italy Anticancer Drugs Market by Therapy Type
10.2.6.3.3 Italy Anticancer Drugs Market by Cancer Type
10.2.6.4 Spain Anticancer Drugs Market
10.2.6.4.1 Spain Anticancer Drugs Market by Drug Type
10.2.6.4.2 Spain Anticancer Drugs Market by Therapy Type
10.2.6.4.3 Spain Anticancer Drugs Market by Cancer Type
10.2.6.5 United Kingdom Anticancer Drugs Market
10.2.6.5.1 United Kingdom Anticancer Drugs Market by Drug Type
10.2.6.5.2 United Kingdom Anticancer Drugs Market by Therapy Type
10.2.6.5.3 United Kingdom Anticancer Drugs Market by Cancer Type
10.2.6.6 Rest of Europe Anticancer Drugs Market
10.2.6.6.1 Rest of Europe Anticancer Drugs Market by Drug Type
10.2.6.6.2 Rest of Europe Anticancer Drugs Market by Therapy Type
10.2.6.6.3 Rest of Europe Anticancer Drugs Market by Cancer Type
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Anticancer Drugs Market Overview
10.3.2 Asia-Pacific Anticancer Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Anticancer Drugs Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Anticancer Drugs Market Forecasts and Analysis - By Therapy Type
10.3.5 Asia-Pacific Anticancer Drugs Market Forecasts and Analysis - By Cancer Type
10.3.6 Asia-Pacific Anticancer Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Anticancer Drugs Market
10.3.6.1.1 Australia Anticancer Drugs Market by Drug Type
10.3.6.1.2 Australia Anticancer Drugs Market by Therapy Type
10.3.6.1.3 Australia Anticancer Drugs Market by Cancer Type
10.3.6.2 China Anticancer Drugs Market
10.3.6.2.1 China Anticancer Drugs Market by Drug Type
10.3.6.2.2 China Anticancer Drugs Market by Therapy Type
10.3.6.2.3 China Anticancer Drugs Market by Cancer Type
10.3.6.3 India Anticancer Drugs Market
10.3.6.3.1 India Anticancer Drugs Market by Drug Type
10.3.6.3.2 India Anticancer Drugs Market by Therapy Type
10.3.6.3.3 India Anticancer Drugs Market by Cancer Type
10.3.6.4 Japan Anticancer Drugs Market
10.3.6.4.1 Japan Anticancer Drugs Market by Drug Type
10.3.6.4.2 Japan Anticancer Drugs Market by Therapy Type
10.3.6.4.3 Japan Anticancer Drugs Market by Cancer Type
10.3.6.5 South Korea Anticancer Drugs Market
10.3.6.5.1 South Korea Anticancer Drugs Market by Drug Type
10.3.6.5.2 South Korea Anticancer Drugs Market by Therapy Type
10.3.6.5.3 South Korea Anticancer Drugs Market by Cancer Type
10.3.6.6 Rest of Asia-Pacific Anticancer Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Anticancer Drugs Market by Drug Type
10.3.6.6.2 Rest of Asia-Pacific Anticancer Drugs Market by Therapy Type
10.3.6.6.3 Rest of Asia-Pacific Anticancer Drugs Market by Cancer Type
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Anticancer Drugs Market Overview
10.4.2 Middle East and Africa Anticancer Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Anticancer Drugs Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Anticancer Drugs Market Forecasts and Analysis - By Therapy Type
10.4.5 Middle East and Africa Anticancer Drugs Market Forecasts and Analysis - By Cancer Type
10.4.6 Middle East and Africa Anticancer Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Anticancer Drugs Market
10.4.6.1.1 South Africa Anticancer Drugs Market by Drug Type
10.4.6.1.2 South Africa Anticancer Drugs Market by Therapy Type
10.4.6.1.3 South Africa Anticancer Drugs Market by Cancer Type
10.4.6.2 Saudi Arabia Anticancer Drugs Market
10.4.6.2.1 Saudi Arabia Anticancer Drugs Market by Drug Type
10.4.6.2.2 Saudi Arabia Anticancer Drugs Market by Therapy Type
10.4.6.2.3 Saudi Arabia Anticancer Drugs Market by Cancer Type
10.4.6.3 U.A.E Anticancer Drugs Market
10.4.6.3.1 U.A.E Anticancer Drugs Market by Drug Type
10.4.6.3.2 U.A.E Anticancer Drugs Market by Therapy Type
10.4.6.3.3 U.A.E Anticancer Drugs Market by Cancer Type
10.4.6.4 Rest of Middle East and Africa Anticancer Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Anticancer Drugs Market by Drug Type
10.4.6.4.2 Rest of Middle East and Africa Anticancer Drugs Market by Therapy Type
10.4.6.4.3 Rest of Middle East and Africa Anticancer Drugs Market by Cancer Type
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Anticancer Drugs Market Overview
10.5.2 South and Central America Anticancer Drugs Market Forecasts and Analysis
10.5.3 South and Central America Anticancer Drugs Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Anticancer Drugs Market Forecasts and Analysis - By Therapy Type
10.5.5 South and Central America Anticancer Drugs Market Forecasts and Analysis - By Cancer Type
10.5.6 South and Central America Anticancer Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Anticancer Drugs Market
10.5.6.1.1 Brazil Anticancer Drugs Market by Drug Type
10.5.6.1.2 Brazil Anticancer Drugs Market by Therapy Type
10.5.6.1.3 Brazil Anticancer Drugs Market by Cancer Type
10.5.6.2 Argentina Anticancer Drugs Market
10.5.6.2.1 Argentina Anticancer Drugs Market by Drug Type
10.5.6.2.2 Argentina Anticancer Drugs Market by Therapy Type
10.5.6.2.3 Argentina Anticancer Drugs Market by Cancer Type
10.5.6.3 Rest of South and Central America Anticancer Drugs Market
10.5.6.3.1 Rest of South and Central America Anticancer Drugs Market by Drug Type
10.5.6.3.2 Rest of South and Central America Anticancer Drugs Market by Therapy Type
10.5.6.3.3 Rest of South and Central America Anticancer Drugs Market by Cancer Type
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTICANCER DRUGS MARKET, KEY COMPANY PROFILES
12.1. ABBVIE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTELLAS PHARMA INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASTRAZENECA PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CELGENE CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. F. HOFFMANN-LA ROCHE LTD.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. JOHNSON AND JOHNSON
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MERCK AND CO., INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SANOFI
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AbbVie Inc.
2. Astellas Pharma Inc.
3. AstraZeneca PLC
4. Celgene Corporation
5. F. Hoffmann-la Roche ltd.
6. Johnson & Johnson
7. Merck & Co., Inc.
8. Novartis AG
9. Pfizer Inc.
10. Sanofi